IL121000A - Process for preparing sildenafil - Google Patents

Process for preparing sildenafil

Info

Publication number: IL121000A
Authority: IL; Israel
Prior art keywords: preparing sildenafil; sildenafil; preparing
Prior art date: 1996-06-14

Application number

IL12100097A

Other languages

English (en)

Other versions

IL121000A0 (en

Original Assignee

Pfizer Res & Dev

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-14

Filing date

1997-06-05

Publication date

2000-02-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10795332&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL121000(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-06-05 Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev

1997-06-05 Priority to IL12541197A priority Critical patent/IL125411A/xx

1997-11-20 Publication of IL121000A0 publication Critical patent/IL121000A0/xx

2000-02-29 Publication of IL121000A publication Critical patent/IL121000A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)

IL12100097A 1996-06-14 1997-06-05 Process for preparing sildenafil IL121000A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IL12541197A IL125411A (en)	1996-06-14	1997-06-05	Preparation of the sildenafil precursor 4-¬2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-benzamido¾-1-methyl 3-n-propylpyrazole-5-carboxamide and the 2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-benzoic acid intermediate therefor

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9612514.1A GB9612514D0 (en)	1996-06-14	1996-06-14	Novel process

Publications (2)

Publication Number	Publication Date
IL121000A0 IL121000A0 (en)	1997-11-20
IL121000A true IL121000A (en)	2000-02-29

Family

ID=10795332

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL12100097A IL121000A (en)	1996-06-14	1997-06-05	Process for preparing sildenafil
IL12541197A IL125411A (en)	1996-06-14	1997-06-05	Preparation of the sildenafil precursor 4-¬2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-benzamido¾-1-methyl 3-n-propylpyrazole-5-carboxamide and the 2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-benzoic acid intermediate therefor
IL12541198A IL125411A0 (en)	1996-06-14	1998-07-20	Sildenafil precursor and process for preparing it

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL12541197A IL125411A (en)	1996-06-14	1997-06-05	Preparation of the sildenafil precursor 4-¬2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-benzamido¾-1-methyl 3-n-propylpyrazole-5-carboxamide and the 2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)-benzoic acid intermediate therefor
IL12541198A IL125411A0 (en)	1996-06-14	1998-07-20	Sildenafil precursor and process for preparing it

Country Status (48)

Country	Link
US (2)	US5955611A (xx)
EP (2)	EP0812845B1 (xx)
JP (2)	JP2866841B2 (xx)
KR (1)	KR100207352B1 (xx)
CN (2)	CN1106399C (xx)
AP (1)	AP717A (xx)
AR (1)	AR003401A1 (xx)
AT (2)	ATE182150T1 (xx)
AU (1)	AU697684B2 (xx)
BG (1)	BG62554B1 (xx)
BR (1)	BR9703580A (xx)
CA (1)	CA2207694C (xx)
CO (1)	CO4780028A1 (xx)
CZ (1)	CZ290942B6 (xx)
DE (2)	DE69700321T2 (xx)
DK (2)	DK0916675T3 (xx)
DZ (1)	DZ2247A1 (xx)
EA (1)	EA000102B1 (xx)
EG (1)	EG24123A (xx)
ES (2)	ES2201397T3 (xx)
GB (1)	GB9612514D0 (xx)
GR (1)	GR3031087T3 (xx)
HK (1)	HK1033459A1 (xx)
HN (1)	HN1997000072A (xx)
HR (1)	HRP970326B1 (xx)
HU (1)	HU224497B1 (xx)
ID (1)	ID18745A (xx)
IL (3)	IL121000A (xx)
IN (5)	IN187350B (xx)
IS (2)	IS1922B (xx)
MA (1)	MA24205A1 (xx)
MX (1)	MX9704433A (xx)
NO (2)	NO304551B1 (xx)
NZ (1)	NZ328084A (xx)
OA (1)	OA10426A (xx)
PE (2)	PE1299A1 (xx)
PL (1)	PL189333B1 (xx)
PT (1)	PT916675E (xx)
RS (2)	RS49653B (xx)
SA (1)	SA97180124B1 (xx)
SG (1)	SG50024A1 (xx)
SI (2)	SI0812845T1 (xx)
SK (5)	SK283896B6 (xx)
TN (1)	TNSN97102A1 (xx)
TR (1)	TR199700470A2 (xx)
UA (1)	UA27085C2 (xx)
UY (2)	UY24585A1 (xx)
ZA (1)	ZA975259B (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060222647A1 (en) *	1993-05-27	2006-10-05	Beavo Joseph A	Methods and compositions for modulating the activity of PDE5
EA004315B1 (ru)	1997-04-25	2004-02-26	Пфайзер Инк.	Новые сульфонилбензойные кислоты и способ получения 4-бензамидопиразоло-5-карбоксамидов с их использованием
KR20010012995A (ko) *	1997-05-29	2001-02-26	모치다 에이	발기부전 치료제
US6399618B1 (en)	1997-07-09	2002-06-04	Cardiome Pharma Corp	Compositions and methods for modulating sexual activity
GB9722520D0 (en)	1997-10-24	1997-12-24	Pfizer Ltd	Compounds
ATE213246T1 (de)	1997-11-12	2002-02-15		2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
HUP0102543A3 (en) *	1998-04-20	2002-01-28	Pfizer	Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction and medicaments containing them
CA2235642C (en)	1998-05-15	2007-11-13	Torcan Chemical Ltd.	Processes for preparing sildenafil
CA2342830C (en) *	1998-09-04	2008-11-25	Ortho-Mcneil Pharmaceutical, Inc.	5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
GB9822238D0 (en) *	1998-10-12	1998-12-09	Pfizer Ltd	Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
GB9823101D0 (en)	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
GB9823103D0 (en) *	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
GB9823102D0 (en)	1998-10-23	1998-12-16	Pfizer Ltd	Pharmaceutically active compounds
KR100353014B1 (ko) *	1998-11-11	2002-09-18	동아제약 주식회사	발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
US6087362A (en) *	1999-03-16	2000-07-11	Pentech Pharmaceuticals, Inc.	Apomorphine and sildenafil composition
CN1094492C (zh) *	1999-06-21	2002-11-20	杭州神鹰医药化工有限公司	西地那非的制备方法
WO2000078760A1 (fr) *	1999-06-21	2000-12-28	The Biochemical Pharmaceutical Factory Of Zhuhai Sez	Procede de preparation de sildenafil, agent et procede d'obtention d'un comprime mixte a base de sildenafil et de chlorhydrate d'apomorphine
CN1077108C (zh) *	1999-07-13	2002-01-02	成都地奥制药集团有限公司	用于制备药物昔多芬的前体化合物
AU1888800A (en) *	1999-09-13	2001-04-17	Cipla Limited	A novel process for the synthesis of sildenafil citrate
US6075028A (en) *	1999-09-23	2000-06-13	Graham; Richard	Method of treating Tourette's syndrome and related CNS disorders
TR200200954T2 (tr)	1999-10-11	2002-09-23	Pfizer Inc.	Fosfodiesteraz inhibitörleri olarak 5-(2-ikame edilmiş-5-heterosiklilsülfonilpirid-3-il)- dihidropirazolo[4,3- D]pirimidin-7-onlar.
TWI265925B (en) *	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
US6667398B2 (en)	2000-06-22	2003-12-23	Pfizer Inc	Process for the preparation of pyrazolopyrimidinones
US6730786B2 (en) *	2000-06-22	2004-05-04	Pfizer Inc	Process for the preparation of pyrazolopyrimidinones
GB0015462D0 (en) *	2000-06-22	2000-08-16	Pfizer Ltd	Novel process for the preparation of pyrazolopyrimidinones
YU84702A (sh) *	2000-06-22	2005-09-19	Pfizer Inc.	Novi postupak za pripremanje pirazolopirimidinona
EP1176142A1 (en) *	2000-07-28	2002-01-30	Pfizer Inc.	Process for the preparation of pyrazoles
YU51701A (sh) *	2000-07-28	2003-12-31	Pfizer Inc.	Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
US6407259B1 (en)	2000-07-28	2002-06-18	Pfizer Inc.	Process for the preparation of pyrazoles
US6821978B2 (en)	2000-09-19	2004-11-23	Schering Corporation	Xanthine phosphodiesterase V inhibitors
CN1127506C (zh) *	2001-06-29	2003-11-12	刘宝顺	一种治疗阳痿的新化合物
US6969719B2 (en) *	2001-08-28	2005-11-29	Schering Corporation	Polycyclic guanine phosphodiesterase V inhibitors
SI1509525T1 (sl)	2002-05-31	2006-12-31	Schering Corp	Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
DE10232113A1 (de)	2002-07-16	2004-01-29	Bayer Ag	Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
CN100374441C (zh)	2003-06-06	2008-03-12	天津倍方科技发展有限公司	二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
CN100360531C (zh) *	2003-12-18	2008-01-09	中国人民解放军军事医学科学院放射与辐射医学研究所	用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
EP1779852A3 (en) *	2004-01-05	2007-05-09	Teva Pharmaceutical Industries Ltd.	Processes for the production of sildenafil base and citrate salt
ES2300979T3 (es)	2004-01-05	2008-06-16	Teva Pharmaceutical Industries Ltd.	Procedimiento para la produccion de sildenafilo base y de su sal citrato.
DE102005009240A1 (de)	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
WO2008074194A1 (fr)	2006-12-21	2008-06-26	Topharman Shanghai Co., Ltd.	Procédé de préparation du sildénafil et de ses intermédiaires
ES2310144B1 (es)	2007-06-15	2010-01-12	Galenicum Health, S.L.	Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
MX339136B (es)	2008-12-12	2016-05-13	Rhein Siegfried Sa De Cv	Composicion de liberacion pulsatil de sildenafil y proceso para prepararla.
MX2010006227A (es)	2010-06-07	2011-12-14	World Trade Imp Exp Wtie Ag	Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
CN102993205B (zh) *	2012-12-27	2015-04-15	华润赛科药业有限责任公司	一种高收率制备高纯度西地那非游离碱的纯化方法
CN103044330B (zh) *	2013-01-14	2018-11-13	常州亚邦制药有限公司	西地那非中间体4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的绿色合成新工艺
CN105085526B (zh) *	2014-05-15	2017-08-01	重庆圣华曦药业股份有限公司	一种改进的西地那非制备方法
CN105753870B (zh) *	2016-04-01	2018-05-22	重庆康刻尔制药有限公司	一种西地那非杂质f及其制备方法和应用
WO2017168174A1 (en)	2016-04-02	2017-10-05	N4 Pharma Uk Limited	New pharmaceutical forms of sildenafil
CN105837578A (zh) *	2016-04-05	2016-08-10	重庆康刻尔制药有限公司	一种西地那非杂质d的合成方法
WO2018069316A2 (en)	2016-10-10	2018-04-19	Transgene Sa	Immunotherapeutic product and mdsc modulator combination therapy
CN113493459B (zh) *	2020-04-07	2022-12-13	广州白云山医药集团股份有限公司白云山制药总厂	Pde5抑制剂化合物及其制备方法和应用
CN112961160A (zh) *	2021-03-05	2021-06-15	遂成药业股份有限公司	一种西地那非的改良合成工艺
CN113754612B (zh) *	2021-10-26	2023-09-26	山东安舜制药有限公司	一种西地那非中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4871843A (en) *	1983-10-18	1989-10-03	Dropic-Societe Civile De Gestion De Droits De Propriete Industrielle	Cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
GB9013750D0 (en) *	1990-06-20	1990-08-08	Pfizer Ltd	Therapeutic agents
GB9114760D0 (en) *	1991-07-09	1991-08-28	Pfizer Ltd	Therapeutic agents
GB9311920D0 (en) *	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
EA004315B1 (ru) *	1997-04-25	2004-02-26	Пфайзер Инк.	Новые сульфонилбензойные кислоты и способ получения 4-бензамидопиразоло-5-карбоксамидов с их использованием
US6087368A (en) *	1998-06-08	2000-07-11	Bristol-Myers Squibb Company	Quinazolinone inhibitors of cGMP phosphodiesterase

1996
- 1996-06-14 GB GBGB9612514.1A patent/GB9612514D0/en active Pending
1997
- 1997-05-14 HN HN1997000072A patent/HN1997000072A/es unknown
- 1997-05-30 NO NO972481A patent/NO304551B1/no not_active IP Right Cessation
- 1997-06-02 AP APAP/P/1997/001009A patent/AP717A/en active
- 1997-06-04 PT PT98123740T patent/PT916675E/pt unknown
- 1997-06-04 EP EP97303832A patent/EP0812845B1/en not_active Expired - Lifetime
- 1997-06-04 AT AT97303832T patent/ATE182150T1/de active
- 1997-06-04 EP EP98123740A patent/EP0916675B1/en not_active Expired - Lifetime
- 1997-06-04 AT AT98123740T patent/ATE246194T1/de active
- 1997-06-04 DK DK98123740T patent/DK0916675T3/da active
- 1997-06-04 SI SI9730005T patent/SI0812845T1/xx not_active IP Right Cessation
- 1997-06-04 DE DE69700321T patent/DE69700321T2/de not_active Expired - Lifetime
- 1997-06-04 DE DE69723846T patent/DE69723846T2/de not_active Expired - Lifetime
- 1997-06-04 DK DK97303832T patent/DK0812845T3/da active
- 1997-06-04 ES ES98123740T patent/ES2201397T3/es not_active Expired - Lifetime
- 1997-06-04 SI SI9730577T patent/SI0916675T1/xx unknown
- 1997-06-04 ES ES97303832T patent/ES2134051T3/es not_active Expired - Lifetime
- 1997-06-05 BG BG101569A patent/BG62554B1/bg unknown
- 1997-06-05 IL IL12100097A patent/IL121000A/xx not_active IP Right Cessation
- 1997-06-05 TR TR97/00470A patent/TR199700470A2/xx unknown
- 1997-06-05 IL IL12541197A patent/IL125411A/xx not_active IP Right Cessation
- 1997-06-06 US US08/869,532 patent/US5955611A/en not_active Expired - Lifetime
- 1997-06-10 SK SK1786-2001A patent/SK283896B6/sk not_active IP Right Cessation
- 1997-06-10 SK SK1787-2001A patent/SK283897B6/sk not_active IP Right Cessation
- 1997-06-10 SK SK1784-2001A patent/SK283895B6/sk not_active IP Right Cessation
- 1997-06-10 IS IS4503A patent/IS1922B/is unknown
- 1997-06-10 SK SK743-97A patent/SK283893B6/sk not_active IP Right Cessation
- 1997-06-10 SA SA97180124A patent/SA97180124B1/ar unknown
- 1997-06-10 IN IN1548DE1997 patent/IN187350B/en unknown
- 1997-06-10 SK SK1783-2001A patent/SK283894B6/sk not_active IP Right Cessation
- 1997-06-11 DZ DZ970097A patent/DZ2247A1/fr active
- 1997-06-11 PE PE1997000483A patent/PE1299A1/es not_active IP Right Cessation
- 1997-06-11 PE PE2001000983A patent/PE20011303A1/es not_active IP Right Cessation
- 1997-06-11 TN TNTNSN97102A patent/TNSN97102A1/fr unknown
- 1997-06-11 MA MA24655A patent/MA24205A1/fr unknown
- 1997-06-11 EA EA199700061A patent/EA000102B1/ru not_active IP Right Cessation
- 1997-06-12 CA CA002207694A patent/CA2207694C/en not_active Expired - Lifetime
- 1997-06-12 UA UA97062802A patent/UA27085C2/uk unknown
- 1997-06-12 AR ARP970102564A patent/AR003401A1/es unknown
- 1997-06-12 SG SG1997002037A patent/SG50024A1/en unknown
- 1997-06-12 EG EG54097A patent/EG24123A/xx active
- 1997-06-12 CZ CZ19971811A patent/CZ290942B6/cs not_active IP Right Cessation
- 1997-06-12 ID IDP972004A patent/ID18745A/id unknown
- 1997-06-13 ZA ZA9705259A patent/ZA975259B/xx unknown
- 1997-06-13 PL PL97320555A patent/PL189333B1/pl not_active IP Right Cessation
- 1997-06-13 HR HR970326A patent/HRP970326B1/xx not_active IP Right Cessation
- 1997-06-13 MX MX9704433A patent/MX9704433A/es unknown
- 1997-06-13 NZ NZ328084A patent/NZ328084A/en not_active IP Right Cessation
- 1997-06-13 JP JP9156422A patent/JP2866841B2/ja not_active Expired - Lifetime
- 1997-06-13 UY UY24585A patent/UY24585A1/es not_active IP Right Cessation
- 1997-06-13 KR KR1019970024457A patent/KR100207352B1/ko not_active IP Right Cessation
- 1997-06-13 RS YUP-254/97A patent/RS49653B/sr unknown
- 1997-06-13 AU AU24878/97A patent/AU697684B2/en not_active Ceased
- 1997-06-13 CO CO97032741A patent/CO4780028A1/es unknown
- 1997-06-13 CN CN97113261A patent/CN1106399C/zh not_active Expired - Lifetime
- 1997-06-13 HU HU9701048A patent/HU224497B1/hu not_active IP Right Cessation
- 1997-06-13 RS YUP-2006/0484A patent/RS49924B/sr unknown
- 1997-06-13 OA OA70024A patent/OA10426A/en unknown
- 1997-06-16 BR BR9703580A patent/BR9703580A/pt not_active IP Right Cessation
- 1997-07-09 UY UY24612A patent/UY24612A1/es not_active IP Right Cessation
1998
- 1998-07-20 IL IL12541198A patent/IL125411A0/xx unknown
- 1998-09-25 JP JP10271067A patent/JP3058863B2/ja not_active Expired - Lifetime
- 1998-10-30 NO NO985064A patent/NO306115B1/no not_active IP Right Cessation
1999
- 1999-07-23 US US09/360,128 patent/US6066735A/en not_active Expired - Lifetime
- 1999-08-26 GR GR990402170T patent/GR3031087T3/el unknown
2000
- 2000-07-05 CN CNB001200542A patent/CN1149206C/zh not_active Expired - Lifetime
2001
- 2001-04-24 IN IN520DE2001 patent/IN187320B/en unknown
- 2001-04-24 IN IN517DE2001 patent/IN187317B/en unknown
- 2001-04-24 IN IN518DE2001 patent/IN187318B/en unknown
- 2001-04-24 IN IN519DE2001 patent/IN187319B/en unknown
- 2001-06-15 HK HK01104141A patent/HK1033459A1/xx not_active IP Right Cessation
2002
- 2002-11-25 IS IS6634A patent/IS1923B/is unknown

Also Published As

Publication number	Publication date
CN1149206C (zh)	2004-05-12
CN1168376A (zh)	1997-12-24
HU224497B1 (hu)	2005-10-28
NO985064D0 (no)	1998-10-30
CZ290942B6 (cs)	2002-11-13
RS49924B (sr)	2008-09-29
PL320555A1 (en)	1997-12-22
EA000102B1 (ru)	1998-08-27
DZ2247A1 (fr)	2002-12-18
ZA975259B (en)	1997-12-15
US6066735A (en)	2000-05-23
IN187318B (xx)	2002-03-23
EP0916675B1 (en)	2003-07-30
BG101569A (en)	1998-01-30
HUP9701048A2 (hu)	1998-12-28
EP0916675A3 (en)	1999-07-14
ATE182150T1 (de)	1999-07-15
PE20011303A1 (es)	2001-12-25
KR100207352B1 (en)	1999-07-15
IS4503A (is)	1997-12-15
SK283894B6 (sk)	2004-04-06
SK283897B6 (sk)	2004-04-06
CO4780028A1 (es)	1999-05-26
IN187350B (xx)	2002-03-30
IN187319B (xx)	2002-03-23
GB9612514D0 (en)	1996-08-14
HRP970326A2 (en)	1998-06-30
DK0812845T3 (da)	1999-11-29
SG50024A1 (en)	1998-06-15
CA2207694A1 (en)	1997-12-14
EP0812845A1 (en)	1997-12-17
PL189333B1 (pl)	2005-07-29
CN1282740A (zh)	2001-02-07
NO972481D0 (no)	1997-05-30
GR3031087T3 (en)	1999-12-31
SA97180124B1 (ar)	2006-02-08
JP2866841B2 (ja)	1999-03-08
SK283896B6 (sk)	2004-04-06
MA24205A1 (fr)	1997-12-31
CA2207694C (en)	1999-11-23
HK1033459A1 (en)	2001-08-31
IS6634A (is)	2002-11-25
IS1922B (is)	2004-03-15
TNSN97102A1 (fr)	2005-03-15
RS20060484A (xx)	2007-04-10
KR980002051A (ko)	1998-03-30
AP717A (en)	1999-01-04
AR003401A1 (es)	1998-08-05
NO972481L (no)	1997-12-15
SI0812845T1 (en)	1999-12-31
ID18745A (id)	1998-05-07
HU9701048D0 (en)	1997-08-28
IL125411A (en)	2000-02-29
AP9701009A0 (en)	1997-07-31
IL121000A0 (en)	1997-11-20
EA199700061A1 (ru)	1997-12-30
UY24612A1 (es)	2000-09-29
EP0812845B1 (en)	1999-07-14
TR199700470A2 (xx)	1998-01-21
SA97180124A (ar)	2005-12-03
MX9704433A (es)	1998-11-30
OA10426A (en)	2001-12-07
AU697684B2 (en)	1998-10-15
DE69723846D1 (de)	2003-09-04
IL125411A0 (en)	1999-03-12
NO306115B1 (no)	1999-09-20
IN187317B (xx)	2002-03-23
NZ328084A (en)	1998-08-26
CN1106399C (zh)	2003-04-23
JPH1081688A (ja)	1998-03-31
JPH11171879A (ja)	1999-06-29
JP3058863B2 (ja)	2000-07-04
BG62554B1 (bg)	2000-02-29
CZ181197A3 (cs)	1998-03-18
EG24123A (en)	2008-07-06
BR9703580A (pt)	1998-11-10
UA27085C2 (uk)	2000-02-28
NO304551B1 (no)	1999-01-11
US5955611A (en)	1999-09-21
EP0916675A2 (en)	1999-05-19
HRP970326B1 (en)	2000-10-31
ES2134051T3 (es)	1999-09-16
IN187320B (xx)	2002-03-23
ES2201397T3 (es)	2004-03-16
SK74397A3 (en)	1998-06-03
NO985064L (no)	1997-12-15
SK283893B6 (sk)	2004-04-06
HUP9701048A3 (en)	2000-10-30
RS49653B (sr)	2007-09-21
HN1997000072A (es)	1997-12-26
SK283895B6 (sk)	2004-04-06
DK0916675T3 (da)	2003-10-27
PT916675E (pt)	2003-11-28
DE69700321T2 (de)	1999-11-04
PE1299A1 (es)	1999-01-13
UY24585A1 (es)	1997-12-02
ATE246194T1 (de)	2003-08-15
YU25497A (sh)	1998-12-23
IS1923B (is)	2004-03-15
DE69700321D1 (de)	1999-08-19
AU2487897A (en)	1997-12-18
SI0916675T1 (en)	2003-12-31
DE69723846T2 (de)	2004-03-04

Publication	Publication Date	Title
EG24123A (en)	2008-07-06	Process for preparing sildenafil
HUP9902419A3 (en)	2002-12-28	Process for preparing nitrobiphenylene
IL129761A0 (en)	2000-02-29	Method for preparing cyclopropylamines
IL134059A0 (en)	2001-04-30	Process for preparing aminoarylacetylenes
HUP9904325A3 (en)	2000-06-28	Process for johexol manufacture
IL122454A (en)	2001-01-28	Process for forming bubble-pack
EG23935A (en)	2008-01-14	Process for preparing eprosartin
EG22077A (en)	2002-07-31	Process for preparing 4-substituted-ih-indole-3 glyoxamides
IL126668A0 (en)	1999-08-17	Improved process for preparing ionones especially beta-ionones
GB2317178B (en)	2000-07-05	Process for preparing 1-chloromethylsilatrane
IL126184A0 (en)	1999-05-09	Process for preparing pentafluoropentanol
HUP0002522A3 (en)	2001-02-28	Process for making benzisothiazolin-3-ones
HUP9904112A3 (en)	2001-07-30	Process for preparing amidines
IL133288A (en)	2003-05-29	Process for preparing 3-isochromanone
IL125646A0 (en)	1999-04-11	Process for preparing n-pyruvyl-l-proline
SI0888261T1 (en)	2002-04-30	Process for preparing nitrobiphenylene
GB9602856D0 (en)	1996-04-10	Process for preparing 4-tert-butyloxycarbonyl-(s) piperazine-2-tert-butylcarboxamide
FI102608B1 (fi)	1999-01-15	Menetelmä alkoholien valmistamiseksi
IL130950A0 (en)	2001-01-28	Process for preparing carboxamido-4- azasteroids
ZA987025B (en)	1999-02-08	Process for preparing 1-pyruvyl-L-proline
SG42360A1 (en)	1997-08-15	Process for the preparation of -caprolactam
HUP9903883A3 (en)	2001-07-30	Method for preparing trimethylbenzoquinone
HUP9903692A3 (en)	2000-07-28	Process for making dihydropyrimidinones
HUT71905A (en)	1996-02-28	Process for preparing 6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylate-3,4-boron-diacetates

Legal Events

Date	Code	Title
2000-06-29	FF	Patent granted
2000-12-06	KB	Patent renewed
2004-02-19	HP	Change in proprietorship
2018-01-31	EXP	Patent expired